Solvent-free protein encapsulation within biodegradable polymer foams

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 11, Issue 5, 2004, Pages 287-293

  Hile, David D ^a   Pishko, Michael V ^b  

^a Texas AandM University   (United States)

^b The Pennsylvania State University   (United States)

Author keywords

Basic Fibroblast Growth Factor; Poly(Lactide Co Glycolide); Protein Encapsulation; Supercritical Carbon Dioxide

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CARBON DIOXIDE; POLYGLACTIN; POLYMER; PROTEIN; SOLVENT; SUPERCRITICAL CARBON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; DISPERSION; ENCAPSULATION; EVAPORATION; FOAM; POROSITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SLOW RELEASE FORMULATION; SOLVENT FREE PROTEIN ENCAPSULATION;

BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CARBON DIOXIDE; DRUG COMPOUNDING; FIBROBLAST GROWTH FACTOR 2; GLYCOLATES; PARTICLE SIZE; POLYMERS; PROTEINS; SOLVENTS; TIME FACTORS;

EID: 4944257149     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540490493961     Document Type: Article

References (48)

1. Babensee, J. E., McIntire, L. V., et al. 2000. Growth factor delivery for tissue engineering. Pharm. Res. 17(5):497-504.
2. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
3. Burg, K., Porter, S., et al. 2000. Biomaterial developments for bone tissue engineering. Biomaterials 21:2347-2359.
4. Chaignaud, B., Langer, R., et al. 1997. The history of tissue engineering using synthetic biodegradable polymer scaffolds and cells. Synthetic Biodegradable Polymer Scaffolds 1-14.
5. Change, S., Park, S., et al. 1998. Phase equilibria of supercritical fluid-polymer systems. J. Supercrit. Fluids 13:113-119.
6. Cima, L., Vacanti, J., et al. 1991. Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng. 113:143-151.
7. Crotts, G., and Park, T. 1997. Stability and release of bovine serum albumin enxcapsulated within poly(D, L-lactide-co-glycolide) microparticles. J. Cont. Rel. 44:123-134.
8. Davies, M. J., Mitchell, C. A., et al. 1997. In vitro assessment of the biological activity of basic fibroblast growth factor released from various polymers and biomatrices. J. Biomater. Appl. 12(1):31-56.
9. Dinbergs, I. D., Brown, L., et al. 1996. Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J. Biol. Chem. 271(47):29822-29929.
10. Edelman, E., Klagsbrun, M., et al. 1991. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12(7):619-626.
11. Estape, D., Heuvel, J. v. d., et al. 1998. Susceptibility towards intramolecular disulphide-bond formation affects conformational stability and folding of human basic fibroblast growth factor. Biochem. J. 335:343-349.
12. Faham, S., Hileman, R., et al. 1996. Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116-1119.
13. Fournier, N., and Doillon, C. 1996. Biological molecule-impregnated polyester: an in vivo angiogenesis study. Biomaterials 17(17):1659-1665.
14. Freed, L. E., Langer, R., et al. 1997. Tissue engineering of cartilage in space. Proc. Natl. Acad. Sci. USA 94(25):13885-13890.
15. Fu, K., Pack, D. W., et al. 2000. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 17(1):100-106.
16. Ghaderi, R., Artursson, P., et al. 1999. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS). Pharm. Res. 16(5):676-681.
17. Giodano, G., Thomson, R., et al. 1997. Retinal pigment epithelium cells cultured on synthetic biodegradable polymers. J. Biomed. Mater. Res. 34:87-93.
18. Giordano, R., Wu, B., et al. 1996. Mechanical properties of dense polylactic acid structures fabricated by three dimensional printing. J. Biomater. Sci. Polymer Edn. 8(1):63-75.
19. Greisler, H. P., Gosselin, C., et al. 1996. Biointeractive polymers and tissue engineered blood vessels. Biomaterials 17(3):329-336.
20. Hile, D., Amirpour, M., et al. 2000. Controlled delivery of active basic fibroblast growth factor from microporous poly(d1-lactide-co-glycolide) foams prepared in supercritical carbon dioxide. J. Cont. Rel. 66:177-185.
21. Holder, W. D., Jr., Gruber, H. E., et al. 1998. Cellular ingrowth and thickness changes in poly-L-lactide and polyglycolide matrices implanted subcutaneously in the rat. J. Biomed. Mater. Res. 41(3):412-421.
22. Kuwano, M., Ushiro, S., et al. 1994. Regulation of angiogenesis by growth factors. Gann Monograph Cancer Res. 42:113-125.
23. Langer, R. 2000. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc. Chem. Res. 33(2):94-101.
24. Langer, R., and Vacanti, J. 1993. Tissue engineering. Science 260:920-926.
25. Lee, K. Y., Peters, M. C., et al. 2000. Controlled growth factor release from synthetic extracellular matrices. Nature 408(6815):998-1000.
26. Li, L., Safran, M., et al. 1994. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis. Biochemistry 33:10999-11007.
27. Lu, L., Peter, S., et al. 2000. In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials 21:1595-1605.
28. Ma, P., Schloo, B., et al. 1995. Development of Biomechanical Properties and Morphogenesis of In Vitro Tissue Engineered Cartilage. J. Biomed. Mater. Res. 29:1587.
29. Mader, K., Bacic, G., et al. 1997. Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging. J. Pharm. Sci. 86(1):126-134.
30. Mikos, A., Lyman, M., et al. 1994a. Wetting of poly(L-lactic acid) and poly(DLlactic-co-glycolic acid) foams for tissue culture. Biomaterials 15(1):55-58.
31. Mikos, A., Thorsen, A., et al. 1994b. Preparation and characterization of poly(L-lactic acid) foams. Polymer 35(5):1068-1077.
32. Mooney, D., Organ, G., et al. 1994. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant. 3(2):203-210.
33. Mooney, D., Sano, K., et al. 1997. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res. 37:413-420.
34. Murphy, W. L., Peters, M. C., et al. 2000. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21(24):2521-2527.
35. Richardson, T. P., Peters, M. C., et al. 2001. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19(11):1029-1034.
36. 2. J. Phys. Chem. 100(38):15581-15587.
37. Roberts, W., and Palade, G. 1995. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108:2369-2379.
38. Schmidt, C., and Baier, J. 2000. A cellular vascular tissues: natural bio-materials for tissue repair and tissue engineering. Biomaterials 21:2215-2231.
39. Sheridan, M. H., Shea, L. D., et al. 2000. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J. Cont. Rel. 64(1-3):91-102.
40. Shieh, Y., Su, J., et al. 1996a. Interaction of supercritical carbon dioxide with polymers. I. Crystalline polymers. J. Appl. Polymer Sci. 59:695-705.
41. Shieh, Y., Su, J., et al. 1996b. Interaction of supercritical carbon dioxide with polymers. II. Amorphous polymers. J. Appl. Polymer Sci. 59:707-717.
42. Singh, L., Kumar, V., et al. 2004. Generation of porous microcellular 85/15 poly (DL-lactide-co-glycolide) foams for biomedical applications. Biomaterials 25(13):2611-2617.
43. Sittinger, M., Bujia, J., et al. 1996. Tissue engineering and autologous transplant formation: practical approaches with resorbable biomaterials and new cell culture techniques. Biomaterials 17(3):237-242.
44. Wang, Y., Shahrokh, Z., et al. 1996. Characterization, stability, and formulations of basic fibroblast growth factor. Pharm. Biotech. 9:141-180.
45. Watson, J. B., Getzler, S. B., et al. 1994. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J. Clin. Invest. 94(1):261-268.
46. Winters, M., Deenedetti, P., et al. 1996. Effects of compressed carbon dioxide on the phase equilibrium and molecular order of a lyotropic polyamide solution. Macromolecules 29(14):4904-4909.
47. Yaszemski, M., Payne, R., et al. 1995. The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng. 1(1):41-52.
48. Zhu, G., Mallery, S. R., et al. 2000. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nat. Biotechnol. 18(1):52-57.